BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 426439)

  • 1. [17-beta estradiol receptors in the normal and pathological human uterus].
    Magli G; De Marco I; Limone M; Di Prisco L
    Ann Ostet Ginecol Med Perinat; 1979; 100(1):47-54. PubMed ID: 426439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on specific markers of hormone-dependence in endometrial carcinoma : estradiol receptors and uterine peroxidase (author's transl)].
    Morikawa S; Sekiya S; Takamizawa H
    Acta Obstet Gynaecol Jpn; 1981 Mar; 33(3):339-43. PubMed ID: 7211223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.
    Wilson EA; Yang F; Rees ED
    Obstet Gynecol; 1980 Jan; 55(1):20-4. PubMed ID: 7352057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estriol binding in uterine corpus cancer and in normal uterine tissues.
    Iida K; Imai A; Tamaya T
    Gen Pharmacol; 1991; 22(3):491-3. PubMed ID: 1869022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor concentration in normal and pathological human uterine tissues.
    Evans LH; Martin JD; Hähnel R
    J Clin Endocrinol Metab; 1974 Jan; 38(1):23-32. PubMed ID: 4358645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in steroid receptors during histopathologic transformation of tissue in the human uterus].
    Ribarac-Stepić N; Sulović V; Matijasević S; Milasin J; Nedeljković Z; Kanazir DT
    Jugosl Ginekol Opstet; 1984; 24(5-6):79-83. PubMed ID: 6535890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of estradiol-17-beta to human cancer tissue of the female genital tract.
    Terenius L; Lindell A; Persson BH
    Cancer Res; 1971 Dec; 31(12):1895-8. PubMed ID: 5120287
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of estrogens P-1496 and P-1560 on the binding of estradiol with rat uterine estrogen receptors.
    Di Carlo F; Conti G; Reboani C; Racca S
    Farmaco Sci; 1980 May; 35(5):425-9. PubMed ID: 7450040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol binding by fibroid tumors and normal myometrium.
    Farber M; Conrad S; Heinrichs WL; Herrmann WL
    Obstet Gynecol; 1972 Oct; 40(4):479-86. PubMed ID: 5073444
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative characteristics of specific binding of estradiol-17beta with proteins-receptors in CBA and C57Bl/6 murine line uterine cytosol during sarcomagenesis induced by 1,2-dimethylhydrazine].
    Morozova OV; Kushlinskiĭ NE
    Biull Eksp Biol Med; 1995 Jan; 119(1):58-62. PubMed ID: 7718806
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of high specific activity [16 alpha-123I]Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors.
    Pavlik EJ; Nelson K; Gallion HH; van Nagell JR; Donaldson ES; Shih WJ; Spicer JA; Preston DF; Baranczuk RJ; Kenady DE
    Cancer Res; 1990 Dec; 50(24):7799-805. PubMed ID: 2253222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of sex steroid receptors in obstetrics and gynecology.
    Roberts DK; Van Sickle M; Kelly RW
    Obstet Gynecol Annu; 1983; 12():61-78. PubMed ID: 6866353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative analysis of progesterone and estradiol reception in human myoma].
    Sergeev PV; Karpeva EN; Tkacheva NIu
    Biull Eksp Biol Med; 1994 Jul; 118(7):33-4. PubMed ID: 7919269
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium.
    Hunter DS; Hodges LC; Vonier PM; Fuchs-Young R; Gottardis MM; Walker CL
    Cancer Res; 1999 Jul; 59(13):3090-9. PubMed ID: 10397250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Properties of alkylating derivatives of estrogens].
    Morozova TM; Merkulova TI; Martynov V; Iaguzhinskaia VP; Shkodinskaia EN
    Eksp Onkol; 1984; 6(2):50-4. PubMed ID: 6510335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multi-component system of estrogen binding proteins from the liver: characterization of binding properties of high molecular weight protein from rat liver similar to uterine estradiol receptors].
    Mataradze GD; Rukaĭia MKh; Smirnov AN; Rozen VB
    Biokhimiia; 1979 Aug; 44(8):1484-92. PubMed ID: 497294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of estrogen receptor levels in endometrial cancer cells.
    Gurpide E; Blumenthal R; Fleming H
    Prog Clin Biol Res; 1984; 142():145-65. PubMed ID: 6709655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [OEstradiol and progesterone steroid hormone receptors in cancer of the endometrium. The significance of the progesterone receptor (author's transl)].
    Martin PM; Rolland PH; Gammerre M; Serment H
    J Gynecol Obstet Biol Reprod (Paris); 1979; 8(8):681-4. PubMed ID: 553927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.